Prevalence and Potential Risk Factors of Peyronie’s Disease: A Cross-Sectional Study of 68 Cases
Archives of Men's Health,
Vol. 8 No. 1 (2024),
31 Mordad 2024
,
Page e7
https://doi.org/10.22037/amh.v8i1.47084
Abstract
Introduction: Peyronie’s disease (PD) is characterized by the formation of fibrous, scar-like tissue in one or more areas of the tunica albuginea. Several potential risk factors for PD have been investigated. We aimed to evaluate the frequency of potential risk factors in PD patients. Methods: In this retrospective cross-sectional study, we included men diagnosed with PD who presented to a referral outpatient urology clinic between March 2019 and August 2024, in Tehran, Iran. Due to the relatively low prevalence of PD and the study's focus on specific risk factors within this population, purposive sampling was employed. The frequency of potential risk factors and the correlation between different risk factors were assessed. Results: A total of 68 patients with PD were studied. The mean age of the disease onset was 53.7 ± 8.0 (range: 28–72) years. The most prevalent risk factors were DM in 20 (29.4%) patients and smoking in 18 (26.5%) patients. There was no significant difference regarding the frequency of risk factors between the two age groups of <55 and ≥55 years (P > 0.05 for all risk factors). Among patients with diabetes mellitus (DM), the median duration of DM since diagnosis was 8.5 (IQR: 2–30) years, while the median duration of hypertension among hypertensive patients was 10 (IQR: 4–20) years. For smokers, the median cumulative smoking exposure was 20 (IQR: 10 – 30) pack-years. Patients who developed PD before the age of 55 had a significantly longer duration of DM compared to those who presented with the disease at ≥55 years (15 vs. 5 years; p = 0.039). Correlation analysis revealed a strong positive correlation between the use of vasoactive erectile drugs and erectile dysfunction (r = 0.64). A negative correlation was observed between a history of penile trauma and age of PD onset (r = -0.40). Conclusion: Based on the findings of the present study, the most frequent potential risk factors were DM and smoking in this series of PD cases. The longer duration of DM may be associated with an earlier onset of PD and its presentation in ages < 55 years.
- Penile Induration
- Erectile Dysfunction
- sexual Dysfunction
- Peyronie’s disease
- Risk factors
- Sexual dysfunction
How to Cite
References
Schubert GE. Anatomy and pathophysiology of Peyronie's disease and congenital deviation of the penis. Urol Int. 1991;47(4):231-5.
Dibenedetti DB, Nguyen D, Zografos L, Ziemiecki R, Zhou X. A Population-Based Study of Peyronie's Disease: Prevalence and Treatment Patterns in the United States. Adv Urol. 2011;2011:282503.
Schwarzer U, Sommer F, Klotz T, Braun M, Reifenrath B, Engelmann U. The prevalence of Peyronie's disease: results of a large survey. BJU Int. 2001;88(7):727-30.
Sommer F, Schwarzer U, Wassmer G, Bloch W, Braun M, Klotz T, et al. Epidemiology of Peyronie's disease. Int J Impot Res. 2002;14(5):379-83.
Smith JF, Walsh TJ, Conti SL, Turek P, Lue T. Risk factors for emotional and relationship problems in Peyronie's disease. J Sex Med. 2008;5(9):2179-84.
Rosen R, Catania J, Lue T, Althof S, Henne J, Hellstrom W, et al. Impact of Peyronie's disease on sexual and psychosocial functioning: qualitative findings in patients and controls. J Sex Med. 2008;5(8):1977-84.
Askari M, Mohamad Mirjalili SA, Bozorg M, Azizi R, Namiranian N. The prevalence of Peyronie's disease in diabetic patients -2018- Yazd. Diabetes Metab Syndr. 2019;13(1):604-7.
Chung E, Gillman M, Rushton D, Love C, Katz D. Prevalence of penile curvature: a population-based cross-sectional study in metropolitan and rural cities in Australia. BJU Int. 2018;122 Suppl 5:42-9.
Jarow JP, Lowe FC. Penile trauma: an etiologic factor in Peyronie's disease and erectile dysfunction. J Urol. 1997;158(4):1388-90.
La Pera G, Pescatori ES, Calabrese M, Boffini A, Colombo F, Andriani E, et al. Peyronie's disease: prevalence and association with cigarette smoking. A multicenter population-based study in men aged 50-69 years. Eur Urol. 2001;40(5):525-30.
Rhoden EL, Teloken C, Ting HY, Lucas ML, Teodósio da Ros C, Ary Vargas Souto C. Prevalence of Peyronie's disease in men over 50 years old from Southern Brazil. Int J Impot Res. 2001;13(5):291-3.
Allameh F, Razzaghi M, Rayegani SM, Fallah-Karkan M, Ranjbar A, Rahavian A, et al. Laser Therapy for Peyronie's Disease: A Randomized Control Double-Blind Pilot Study. J Lasers Med Sci. 2019;10(Suppl 1):S37-s42.
Gianazza S, Belladelli F, Leni R, Masci F, Rossi P, Gianesini G, et al. Peyronie's disease development and management in diabetic men. Andrology. 2023;11(2):372-8.
El-Sakka AI. Prevalence of Peyronie's disease among patients with erectile dysfunction. Eur Urol. 2006;49(3):564-9.
Hazar N, Jokar M, Namavari N, Hosseini S, Rahmanian V. An updated systematic review and Meta-analysis of the prevalence of type 2 diabetes in Iran, 1996-2023. Front Public Health. 2024;12:1322072.
Allameh M, Ghanei Gheshlagh R, Rahmani K. Prevalence and Associated Risk Factors of Hypertension for the Middle-Aged Population (30-59 Years) in Iran: A National Cross-Sectional Study. High Blood Press Cardiovasc Prev. 2022;29(1):75-80.
Crocetto F, Barone B, Manfredi C, Trama F, Romano L, Romeo M, et al. Are insulin resistance and non-alcoholic fatty liver disease associated with Peyronie's disease? A pilot study. J Physiol Pharmacol. 2022;73(1).
Karakus S, Unal S, Dai D, Joseph C, Du Comb W, Levy JA, et al. Early-onset and uncontrolled diabetes mellitus factors correlate with complications of Peyronie's disease. J Sex Med. 2024;21(8):716-22.
Paulis G, De Giorgio G, Paulis A. Clinical Presentation of Peyronie's Disease: A Retrospective Study of 564 Cases. Diagnostics (Basel). 2024;14(11).
Deveci S, Palese M, Parker M, Guhring P, Mulhall JP. Erectile function profiles in men with Peyronie's disease. J Urol. 2006;175(5):1807-11; discussion 11.
- Abstract Viewed: 171 times
- pdf Downloaded: 135 times